title: Response to letter regarding article, "Randomized assessment of ticagrelor versus prasugrel antiplatelet effects in patients with ST-segment-elevation myocardial infarction".
authors.forename: Dimitrios
authors.initials: D
authors.lastname: Alexopoulos
authors.forename: Ioanna
authors.initials: I
authors.lastname: Xanthopoulou
authors.forename: Vassilios
authors.initials: V
authors.lastname: Gkizas
authors.forename: George
authors.initials: G
authors.lastname: Kassimis
authors.forename: Konstantinos
authors.initials: K
authors.lastname: Theodoropoulos
authors.forename: George
authors.initials: G
authors.lastname: Makris
authors.forename: Nikolaos
authors.initials: N
authors.lastname: Koutsogiannis
authors.forename: Anastasia
authors.initials: A
authors.lastname: Damelou
authors.forename: Grigorios
authors.initials: G
authors.lastname: Tsigkas
authors.forename: Periklis
authors.initials: P
authors.lastname: Davlouros
authors.forename: George
authors.initials: G
authors.lastname: Hahalis
mesh_terms: D000241:Adenosine / Q000031:analogs & derivatives*; D001792:Blood Platelets / Q000187:drug effects*; D005260:Female; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000628:therapy*; D062645:Percutaneous Coronary Intervention; D010879:Piperazines / Q000627:therapeutic use*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D058921:Purinergic P2Y Receptor Antagonists / Q000627:therapeutic use*; D013876:Thiophenes / Q000627:therapeutic use*
chemical_list: D010879:Piperazines; D010975:Platelet Aggregation Inhibitors; D058921:Purinergic P2Y Receptor Antagonists; D013876:Thiophenes; D000241:Adenosine